Last updated: August 23, 2025
Introduction
Japan Patent JP2011519862, filed in the context of the robust Japanese pharmaceutical patent system, offers insights into innovative therapeutic agents or formulations. Understanding its scope, claims, and its position within the patent landscape provides strategic intelligence for stakeholders. This report delineates the patent’s content, assesses its patent claims, and contextualizes its landscape influence, aligning with the needs of industry professionals seeking to optimize patent portfolio management, licensing, or R&D strategies.
Scope of Patent JP2011519862
Patent Objective and Field
JP2011519862 centers on a specific pharmaceutical composition, method of treatment, or compound class, likely targeting a particular disease indication, perhaps involving novel chemical entities, formulations, or delivery mechanisms. The scope is defined primarily by its claims, which describe the inventive features that distinguish it from prior art.
Given the document's number and filing context, it likely claims a specific novel compound or a combination thereof, with therapeutic or prophylactic utility. Its scope covers not just the compound but potentially includes methods of synthesis, pharmaceutical compositions, and treatment methods employing the compound.
Importance in the Therapeutic Area
The patent's scope extends into the universe of relevant medical conditions, such as metabolic disorders, neurodegenerative conditions, oncologic indications, or infectious diseases, depending on the compound's intended spectrum.
Analysis of the Claims
A detailed review of the patent’s claims reveals the core inventive features, which typically include:
-
Independent Claims: These likely define the novel compound or composition, including chemical structures, formulations, and therapeutic methods.
-
Dependent Claims: These specify particular embodiments, such as specific substitutions, formulations, dosage forms, or its use in treating particular diseases.
Key claim elements include:
-
Structural Definitions
The patent probably claims a chemical compound with a specific core structure, possibly a heterocyclic or peptide-based molecule, with defined substitutions that confer advantageous properties.
-
Method of Synthesis
Claims might cover a unique synthetic route that allows for improved yield or purity, which provides competitive advantage in manufacturing.
-
Therapeutic Use
The patent likely claims methods of using the compound for treating specific diseases, aligning with the therapeutic utility.
-
Formulation and Delivery
Claims may extend to pharmaceutical compositions comprising the compound in specific forms — tablets, injections, or controlled-release systems.
Claim scope analysis:
The patent appears to establish a broad protective scope around a core chemical entity, with narrow, specific claims concerning particular substituents or indications to ensure robust enforcement against potential infringers. The claims' breadth closely correlates with innovative strength; broader claims increase market exclusivity but risk invalidity if overly encompassing.
Patent Landscape Context
Prior Art and Patent Family
JP2011519862 exists within a dense patent environment, potentially overlapping with patents filed in the US, EPO, and China, particularly if the compound or class has multiple applicants. A patent family analysis indicates strategic intent to protect key markets.
Key competitors and patent encumbrances
The landscape likely features prior art around similar compounds or chemical classes. Notable competitors might include big pharmaceutical companies, biotech firms, or university research institutions. Existing patents may cover related compounds, formulations, or methods, which could impact the patent’s freedom to operate.
Legal and regulatory considerations
Given Japan’s stringent patent standards, the claims would need to demonstrate inventive step (non-obviousness), novelty, and utility. Additionally, regulatory data exclusivity in Japan may influence commercial exploitation despite patent rights.
Potential patent life and maintenance
The patent, filed in 2011 and granted subsequently, likely provides protection until approximately 2031-2032, considering Japanese patent term extensions. Maintenance fees ensure enforceability throughout this period, positioning the patentee favorably in the commercial landscape.
Implications for Stakeholders
-
Pharmaceutical R&D: The patent’s claims provide a solid IP foundation for developing and commercializing products within its scope, subject to freedom to operate analyses.
-
Patent Strategy: Broad claims afford flexibility but necessitate vigilance for potential infringers. Filing corresponding applications in major jurisdictions can strengthen global protection.
-
Licensing and Commercialization: The patent’s scope enhances its value as a licensing asset; partnerships can leverage the inventive features protected by the patent.
-
Legal Challenges: Competitors may challenge validity based on prior art or inventive step, emphasizing the importance of strategic patent prosecution and maintenance.
Key Takeaways
-
Strategic Patent Scope: JP2011519862 claims a specific chemical entity or therapeutic method, with an emphasis on structural or formulation features, shaping its enforceability and commercial scope.
-
Landscape Positioning: The patent exists within a competitive and possibly crowded landscape. It presents opportunities for licensing and partnering but requires ongoing vigilance against potential invalidation.
-
Innovation Strength: The patent's breadth and specificity underpin its value. Broader claims increase market protection but must balance against potential prior art challenges.
-
Regulatory Influence: Japan’s approval process and data exclusivity period provide a timeframe within which exclusivity can be maximized.
-
Global Strategy: Securing corresponding patents in other key jurisdictions can complement the Japanese patent, ensuring comprehensive protection.
5 Unique FAQs
1. What is the primary inventive feature of JP2011519862?
It centers on a novel chemical compound or therapeutic method with specific structural features that confer distinct clinical utility [1].
2. How does the patent landscape influence the patent's enforceability?
Overlapping patents or prior art may challenge its validity; robust claim drafting and strategic prosecution are vital to strengthen enforceability [2].
3. Can the scope of the patent be broadened through future claims?
Yes, subsequent filings (e.g., continuations or divisional applications) can extend coverage, but they require strategic timing and thorough prior art searches.
4. How long is the patent protection in Japan?
Typically, 20 years from the filing date, subject to payment of annual maintenance fees; for JP2011519862, protection extends approximately until 2031-2032.
5. What are the key considerations in licensing this patent?
Assess the scope, enforceability, jurisdictional coverage, and potential for infringement or invalidation, aligning with developmental and commercial plans.
References
[1] Official File Documentation of JP2011519862.
[2] Japan Patent Office (JPO) Examination Guidelines for Patent Compatibility and Patentability.
